3M™ V.A.C.® Therapy delivers lower total cost to treat

Two large independent* economic studies demonstrated:

3M™ V.A.C.® Therapy delivers lower total cost to treat^1,2

^{* Data owned and analyzed by third party; analysis funded by 3M.}

The newest health economic analysis² of real-world health insurance claims data provided insights into the cost-effectiveness of negative pressure wound therapy (NPWT). The analysis showed patients who received V.A.C.® Therapy had lower total and wound-related treatment costs than patients who received competitor NPWT in all wound types across all time periods studied.

Methodology²

Retrospective analysis of U.S. insurance claims database compared total and wound-related costs for patients who received V.A.C.® Therapy versus competitor NPWT in the outpatient setting between January 2016 and September 2018. Costs were compared across care settings and wound types at 30 days, 3 months, and 12 months after initial claim.

^References:

^{1. Law A, Cyhaniuk A, Krebs B. Comparison of health care costs and hospital readmission rates associated with negative pressure wound therapies. Wounds. 2015 Mar;27(3):63-72. PMID: 25786078.}

^{2. Law A L. Krebs B. Karnik B. Griffin L. Comparison of Healthcare Costs Associated With Patients Receiving Traditional Negative Pressure Wound Therapies in the Post Acute Setting. Cureus 12(11): e11790. DOI 10.7759/cureus.11790.}

^{NOTE: Specific indications, contraindications, warnings, precautions, and safety information exist for these products and therapies. Please consult a clinician and product instructions for use prior to application. Rx only.}

^{© 2021 3M. All rights reserved. 3M and the other marks shown are marks and/or registered marks. Unauthorized use prohibited.}

^{PRA-PM-US-03086 (07/21)}